Symptoms and General Pathology

All Conditions

Neoplasms

Rare Diseases

Recurrence

Carcinoid Tumor

Neuroendocrine Tumors

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms by Histologic Type

Adenocarcinoma

Carcinoma

Neoplasms, Glandular and Epithelial

Neoplasms, Nerve Tissue

Bronchial Adenomas/carcinoids Childhood

Neuroendocrine Tumor

Neuroepithelioma

Patient with endoscopic treatment will be included. Some medical data collection by medical record will be collected.

Medical data collection by medical record will be collected: demographics data, medical history, clinical symptoms, smoking, type of endoscopic method, complete treatment or not, type of surgeries if yes, anatomopathology of the injury and recurrence if yes

Medical data collection

Jean-Michel VERGNON, PhD

Carcinoid tumors of the lung are considered to be a low-grade malignancy. Surgical resection is considered the standard approach. Recent data has shown that a complete endoscopic treatment could be considered. An endoscopic treatment is can be a alternative to invasive surgery.

The objective of this study is to evaluate the feasibility and therapeutic method of endoscopic treatment of bronchial carcinoid tumors.

Endoscopic Treatment of Bronchial Carcinoid Tumors

Feasibility and Therapeutic Method of Endoscopic Treatment of Bronchial Carcinoid Tumors: 22 Years Experience of Saint-Etienne

patients who have a complete endoscopic treatment

Analysis the deadline before recurrence of the tumor.

Centre Hospitalier Universitaire de Saint Etienne

Respiratory Tract (Lung and Bronchial) Diseases

Lung Neoplasms

Airway Obstruction

Respiratory Tract Diseases

Respiratory Insufficiency

Respiration Disorders

Medical information collected after bronchoscopy for up to 2 years.

Medical Data Collection

David Ost, MD

The goal of this clinical research study is learn about side effects and the success of bronchoscopies when performed in cancer patients with and without symptoms.

This is an investigational study.

Up to 110 patients will take part in this study. All will be enrolled at MD Anderson.

If participant agrees to take part in this study, researchers will collect information from participant's medical records.

Length of Study:

Researchers will continue to collect participant's medical information for up to 2 years.

Additional Information:

Participant's data will be kept in a database on a password-protected computer in a secure office. This information will only be available to the study doctors and staff.

Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction

Comparative Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction

Early intervention cases defined as those with anatomic narrowing and no or mild dyspnea (as measured by the Borg score).

Late intervention cases defined as those with moderate or severe dyspnea due to airway narrowing.

Researchers will estimate the hazard function of time to any complications in the framework of competing risks while death is the competing risk.3 Researchers will graphically visualize the hazard function of time to any complications using Kernel smoothing method.

Researchers will evaluate the relationship between covariates and quality-adjusted survival.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Endoscopic Treatment of Bronchial Carcinoid Tumors	NCT03723499	Carcinoid Tumor	Medical data co...	18 Years -	Centre Hospitalier Universitaire de Saint Etienne
Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction	NCT03326570	Lung Cancer	Medical Data Co...	18 Years -	M.D. Anderson Cancer Center
Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction	NCT03326570	Lung Cancer	Medical Data Co...	18 Years -	M.D. Anderson Cancer Center

Spots Global Cancer Trial Database for medical data collection